Welcome to Pharma Pulse, a Pharmaceutical Commerce podcast where we bring you the latest insights shaping patient access, supply chain/logistics, data & tech, and healthcare innovation. I’m your host, and today we’re covering new controversy surrounding the NIAID, emerging research on ALS, and growing workforce challenges across US hospitals.

• A former National Institute of Allergy and Infectious Diseases (NIAID) director has alleged she was fired in retaliation for whistleblower complaints. The former official claims her termination followed reports of internal misconduct and mismanagement within the agency. The allegations are now drawing scrutiny from federal oversight bodies, reigniting debate over transparency, accountability, and the treatment of whistleblowers in federally funded research institutions.
• In groundbreaking research, scientists now believe amyotrophic lateral sclerosis, or ALS, may have an autoimmune component. The study identified immune cells attacking motor neurons, suggesting that immunotherapy could one day slow or alter disease progression. This discovery marks a potential paradigm shift in understanding ALS and opens the door for new treatment approaches beyond symptom management.
• Lastly, in healthcare operations, hospitals nationwide have laid off thousands of workers since June, citing financial strain, rising labor costs, and declining reimbursements. The cuts have affected both clinical and administrative roles, with smaller and rural...

Read Full Story: https://news.google.com/rss/articles/CBMikgFBVV95cUxNUERKQW04VHI1WURrOG0zeVJx...